TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
Not only do we take too many drugs, they’re making us sicker… The United States has one of the highest rates in the world of prescription drug use, especially for the psychiatric and anti-anxiety drug classes: 1 in 6 Americans takes a psychiatric drug Over a 130,000 U.S. toddlers, children between zero and five years Read More…
Medical News Today reports that, in 2011, there was a modest uptick in the number of prescriptions written in the US. The increase brought the total to: 4.02 billion. Yes, in 2011, doctors wrote 4.02 billion prescriptions for drugs in America. That’s an average of roughly 13 prescriptions for each man, woman, and child. That’s Read More…
A worrisome trend has emerged in the last few decades that many physicians are choosing to ignore: As the amount of psychiatric drug prescriptions increase, our mental health declines. It’s time we swallow the hard pill and ask ourselves, are psychiatrists doing more harm than good? I know that, to some of you, this question seems absurd. Why would licensed Read More…
Congress would rather protect the profits of pharmaceutical companies than the health of those addicted to dangerous opioid drugs, says a former head of the DEA responsible for preventing abuse of medications. Joseph Rannazzisi, former Deputy Assistant Administrator at the U.S. Drug Enforcement Agency, asserts Big Pharma and its lobbyists have a “stranglehold” on legislators in Congress Read More…
The U.S. Drug Enforcement Agency wants to access a Utah database of confidential prescription records. But the feds have a problem. The state requires a warrant before law enforcement agencies can access the Utah Controlled Substance Database. The DEA doesn’t have one. Not to be deterred, the drug police have sued the state in federal Read More…
When pharmaceutical companies create a new drug, they are always looking for compounds that treat specific profitable disorders, especially if they have the potential for blockbuster status. Patent life is 20 years after the drug has been identified as viable in clinical trials – this means that no one else can make or sell the Read More…